The briefing
Inside Precision Medicine reports that relying solely on BRCA testing may miss about 42% of hereditary cancer risk. The findings suggest broader genetic panels and attention to family history could identify additional at‑risk individuals, including relatives of breast and ovarian cancer patients.
Original headline
BRCA Tests Alone Miss 42% of Hereditary Cancer Risk